| Investment Ideas (51) | Know-how (9) |
| MeinIndex products (11) | Theme Investing (32) |
| Yield Enhancement (190) |
Two years ago, everyone was talking about the Metaverse. But who is talking about the Metaverse today? Artificial intelligence is the number one topic of conversation. But is the Metaverse really dead, or is it a long-term trend that we'll be hearing about again soon?
Gold is trading at record highs, defying traditional patterns. What is behind the gold rally and how can investors invest responsibly?
Lithium, cobalt, and nickel are indispensable for electric mobility, but their procurement presents challenges. Through innovative recycling methods, these valuable materials can be efficiently reused.
The luxury goods sector experienced a turbulent year. However, the market as a whole is expected to continue growing. The tracker certificate of Zürcher Kantonalbank offers investors wishing to participate in the sector's performance a simple and efficient access.
Tracker certificates provide quick and easy access to investment themes. Find out more about the mechanics of the products in the video.
A dividend strategy can be attractive for investors who want to generate a steady income from their equity exposure. However, a sustainable and reliable distribution policy is key. The tracker certificate from Zürcher Kantonalbank provides simple and efficient access to a global dividend basket.
The research at Zürcher Kantonalbank has identified ten equity top picks for the new year. The tracker certificate on the «ZKB Favourite Stocks 2024» allows investors to participate in this selection.
Apple's Vision Pro headset is set to shake up the reality technology market. The initial buzz has died down, so now seems a good time to take a closer look at the potential beneficiaries of this new product category.
Thanks to technological advances, medical insight into the human body is becoming increasingly precise, facilitating the early diagnosis of diseases. Endoscopes and diagnostic test systems make a significant contribution to this progress. The industry is characterised by a high rate of innovation, developing products that help to treat patients quickly and gently. The pace of innovation is likely to remain above average in the future.
| ZKB Autocallable Barrier Reverse Convertible on worst of Clariant AG/Ypsomed Holding AG/BACHEM HOLDI... 139434198 / CH1394341981 |
| ZKB Autocallable Barrier Reverse Convertible on worst of Clariant AG/BACHEM HOLDING AG/Comet Holding... 139434172 / CH1394341726 |
| ZKB Barrier Reverse Convertible auf Delivery Hero SE 144653079 / CH1446530797 |
| ZKB Callable Barrier Reverse Convertible on worst of Julius Baer Gruppe AG/Sandoz Group AG/Clariant ... 140252325 / CH1402523257 |
| ZKB Barrier Reverse Convertible on worst of Eli Lilly & Co/Lonza Group AG/Sika AG 140249690 / CH1402496900 |